相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oncolytic viruses: smart therapeutics for smart cancers
Rebecca Auer et al.
FUTURE ONCOLOGY (2012)
TroVax® vaccine therapy for renal cell carcinoma
Rui-Tao Zhang et al.
IMMUNOTHERAPY (2012)
Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer
Marie L. Huber et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Dan H. Barouch et al.
NATURE (2012)
Vaccine Vectors Derived from a Large Collection of Simian Adenoviruses Induce Potent Cellular Immunity Across Multiple Species
Stefano Colloca et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Novel Adenovirus-Based Vaccines Induce Broad and Sustained T Cell Responses to HCV in Man
Eleanor Barnes et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Ipilimumab: A Novel Treatment for Metastatic Melanoma
Morgan E. Culver et al.
ANNALS OF PHARMACOTHERAPY (2011)
DNA fusion vaccines enter the clinic
Freda K. Stevenson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Intra-Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial
Antoni Ribas et al.
CLINICAL CANCER RESEARCH (2011)
Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors
Stephen R. Walsh et al.
EXPERT REVIEW OF VACCINES (2011)
Therapeutic cancer vaccines: are we there yet?
Christopher A. Klebanoff et al.
IMMUNOLOGICAL REVIEWS (2011)
DNA vaccines: an historical perspective and view to the future
Margaret A. Liu
IMMUNOLOGICAL REVIEWS (2011)
Immunologic therapy targeting metastatic melanoma: Allovectin-7 (R)
Rozina Chowdhery et al.
IMMUNOTHERAPY (2011)
Recent Developments in Cancer Vaccines
Karolina Palucka et al.
JOURNAL OF IMMUNOLOGY (2011)
A Phase 1 Study of a Vaccine Targeting Preferentially Expressed Antigen in Melanoma and Prostate-specific Membrane Antigen in Patients With Advanced Solid Tumors
Jeffrey S. Weber et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial
Elisabeth Quoix et al.
LANCET ONCOLOGY (2011)
Phase Ia Clinical Evaluation of the Plasmodium falciparum Blood-stage Antigen MSP1 in ChAd63 and MVA Vaccine Vectors
Susanne H. Sheehy et al.
MOLECULAR THERAPY (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Cancer immunology-analysis of host and tumor factors for personalized medicine
Shuji Ogino et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations
Dan H. Barouch et al.
VACCINE (2011)
Emerging Cancer Vaccines: The Promise of Genetic Vectors
Luigi Aurisicchio et al.
Cancers (2011)
Clinical and immunological responses in metastatic melanoma patients vaccinated with a high-dose poly-epitope vaccine
Adam Dangoor et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Adoptive Cell Therapy Genetic Modification to Redirect Effector Cell Specificity
Richard A. Morgan et al.
CANCER JOURNAL (2010)
A Better Immune Reaction to Erbb-2 Tumors Is Elicited in Mice by DNA Vaccines Encoding Rat/Human Chimeric Proteins
Elena Quaglino et al.
CANCER RESEARCH (2010)
Vaccination of Metastatic Renal Cancer Patients with MVA-5T4: A Randomized, Double-Blind, Placebo-Controlled Phase III Study
Robert J. Amato et al.
CLINICAL CANCER RESEARCH (2010)
Adenovirus Vector Production and Purification
Ana Carina Silva et al.
CURRENT GENE THERAPY (2010)
Oncolytic (replication-competent) adenoviruses as anticancer agents
Karoly Toth et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma
Howard L. Kaufman et al.
FUTURE ONCOLOGY (2010)
Trovax, a recombinant modified vaccinia ankara virus encoding 5T4
Dae Won Kim et al.
HUMAN VACCINES (2010)
JAVMA News
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2010)
An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer
Michael A. Morse et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
Philip W. Kantoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A Vaccine Targeting Telomerase Enhances Survival of Dogs Affected by B-cell Lymphoma
Daniela Peruzzi et al.
MOLECULAR THERAPY (2010)
Viruses as vaccine vectors for infectious diseases and cancer
Simon J. Draper et al.
NATURE REVIEWS MICROBIOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Alphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity
Francesca Avogadri et al.
PLOS ONE (2010)
Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs
Daniela Peruzzi et al.
VACCINE (2010)
A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine
Antonella Conforti et al.
VACCINE (2010)
Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime-boost immunisation in non-human primates
Stefania Capone et al.
VACCINE (2010)
An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models
S. Dharmapuri et al.
CANCER GENE THERAPY (2009)
Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer-Specific Immune Responses and Their Correlation to Prognosis
Christoph Domschke et al.
CANCER RESEARCH (2009)
Treatment of Mammary Carcinomas in HER-2 Transgenic Mice through Combination of Genetic Vaccine and an Agonist of Toll-Like Receptor 9
Luigi Aurisicchio et al.
CLINICAL CANCER RESEARCH (2009)
MMP11: A Novel Target Antigen for Cancer Immunotherapy
Daniela Peruzzi et al.
CLINICAL CANCER RESEARCH (2009)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Engineered adenovirus serotypes for overcoming anti-vector immunity
Sridhar Dharmapuri et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer
Ravi A. Madan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
A Therapeutic Cancer Vaccine Targeting Carcinoembryonic Antigen in Intestinal Carcinomas
Federica Mori et al.
HUMAN GENE THERAPY (2009)
ErbB2 Genetic Cancer Vaccine in Nonhuman Primates: Relevance of Single Nucleotide Polymorphisms
Elena Fattori et al.
HUMAN GENE THERAPY (2009)
DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer
Lindsey Low et al.
HUMAN GENE THERAPY (2009)
Antiapoptotic Small Interfering RNA as Potent Adjuvant of DNA Vaccination in a Mouse Mammary Tumor Model
Sridhar Dharmapuri et al.
HUMAN GENE THERAPY (2009)
New Insights on Adenovirus as Vaccine Vectors
Marcio O. Lasaro et al.
MOLECULAR THERAPY (2009)
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
Daniela Peruzzi et al.
VACCINE (2009)
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer
Carmela Mennuni et al.
CANCER RESEARCH (2008)
Therapeutic vaccination halts disease progression in BALB-neuT mice:: The amplitude of elicited immune response is predictive of vaccine efficacy
Barbara Cipriani et al.
HUMAN GENE THERAPY (2008)
RNA interference-mediated in vivo silencing of fas ligand as a strategy for the enhancement of DNA vaccine potency
Bruce Huang et al.
HUMAN GENE THERAPY (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects
Andrea Facciabene et al.
VACCINE (2007)
Alphaviral vector-transduced dendritic cells are successful therapeutic vaccines against neu-overexpressing tumors in wild-type mice
Timothy P. Moran et al.
VACCINE (2007)
A novel alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses
Robert J. Durso et al.
CLINICAL CANCER RESEARCH (2007)
Immunogenicity and safety of a DNA prime/adenovirus boost vaccine against rhesus CEA in nonhuman primates
Luigi Aurisicchio et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D
Peter Abbink et al.
JOURNAL OF VIROLOGY (2007)
Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates
Stefania Capone et al.
JOURNAL OF IMMUNOLOGY (2006)
Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity
Angelique A. C. Lemckert et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Chimpanzee-origin adenovirus vectors as vaccine carriers
N Tatsis et al.
GENE THERAPY (2006)
Development of nonhuman adenoviruses as vaccine vectors
DS Bangari et al.
VACCINE (2006)
DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protection
A Facciabene et al.
HUMAN GENE THERAPY (2006)
Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus
M Perreau et al.
JOURNAL OF VIROLOGY (2005)
Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA
C Mennuni et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-Ad5 immunity
AAC Lemckert et al.
JOURNAL OF VIROLOGY (2005)
DNA electrotransfer:: its principles and an updated review of its therapeutic applications
F André et al.
GENE THERAPY (2004)
Recombinant ovine atadenovirus induces a strong and sustained T cell response against the hepatitis C virus NS3 antigen in mice
T Wüest et al.
VACCINE (2004)
Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture
DS Bangari et al.
VIRUS RESEARCH (2004)
Codon optimizer: a freeware tool for codon optimization
A Fuglsang
PROTEIN EXPRESSION AND PURIFICATION (2003)
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination:: Efficient human cell infection and bypass of preexisting adenovirus immunity
R Vogels et al.
JOURNAL OF VIROLOGY (2003)
Development of adenovirus serotype 35 as a gene transfer vector
PS Reddy et al.
VIROLOGY (2003)
Gene etectro-transfer improves transduction by modifying the fate of intramuscutar DNA
M Cappelletti et al.
JOURNAL OF GENE MEDICINE (2003)
Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses
JL Marshall et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus
R Stratford et al.
VACCINE (2000)
Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure
G Rizzuto et al.
HUMAN GENE THERAPY (2000)
分享论文
